A dynamic model for estimating changes in health status and costs

被引:19
作者
Gardiner, Joseph C.
Luo, Zhehui
Bradley, Cathy J.
Sirbu, Corina A.
Given, Charles W.
机构
[1] Michigan State Univ, Div Biostat, Dept Epidemiol, E Lansing, MI 48824 USA
[2] Virginia Commonwealth Univ, Dept Hlth Adm, Richmond, VA 23284 USA
[3] Boston Sci Corp, Natick, MA 01760 USA
[4] Michigan State Univ, Dept Family Practice, E Lansing, MI 48824 USA
关键词
longitudinal data; Markov model; mixed-effects model; medical costs; net present value; regression analysis;
D O I
10.1002/sim.2484
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We develop an innovative method to assess total treatment costs over a finite period of time while incorporating the dynamics of change in the health status of patients. Costs are incurred through medical care use while patients sojourn in health states. Because complete ascertainment of costs and observation of events are not always feasible, some patient utilization will be incomplete and events will also be censored. A Markov model is used to estimate the transition probabilities between health states and the impact of patient variables on transition intensities. A mixed-effects model is used for sojourn costs with transition times as random effects and patient variables as fixed effects. The models are combined to estimate net present values (NPVs) of expenditures over a finite time interval as a function of patient characteristics. The method is applied to a data set of 624 incident cases of cancer. Physical functioning after cancer diagnosis was assessed periodically through structured interviews. The outcomes of interest are normal physical function, impaired physical function, or the terminal state, dead. Charges were obtained from Medicare claim files for 2 years following cancer diagnosis. For demonstration purposes, we estimate NPVs for charges incurred over 2 years by cancer site and cancer stage. Our method, a joint regression model, provides a flexible approach to assessing the influence of patient characteristics on both cost and health outcomes while accommodating heteroscedasticity, skewness and censoring in the data. Copyright (c) 2006 John Wiley & Sons, Ltd.
引用
收藏
页码:3648 / 3667
页数:20
相关论文
共 51 条
  • [1] Standard errors for the retransformation problem with heteroscedasticity
    Ai, CR
    Norton, EC
    [J]. JOURNAL OF HEALTH ECONOMICS, 2000, 19 (05) : 697 - 718
  • [2] Andersen P. K., 2012, Statistical models based on counting processes
  • [3] Andersen PK, 2000, STAT MED, V19, P587, DOI 10.1002/(SICI)1097-0258(20000229)19:4<587::AID-SIM358>3.0.CO
  • [4] 2-0
  • [5] Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra
  • [6] ANDERSEN PK, 1991, SCAND J STAT, V18, P153
  • [7] [Anonymous], 2002, HEALTH SERV OUTCOME, DOI DOI 10.1023/A:1024264224760
  • [8] Deriving a compound quality of life measure from the EORTC-QLQ-C30/LC13 instrument for use in economic evaluations of lung cancer clinical trials
    Bagust, A
    Barraza-Llorens, M
    Philips, Z
    [J]. EUROPEAN JOURNAL OF CANCER, 2001, 37 (09) : 1081 - 1088
  • [9] Estimating medical costs with censored data
    Bang, H
    Tsiatis, AA
    [J]. BIOMETRIKA, 2000, 87 (02) : 329 - 343
  • [10] Baser O, 2004, VALUE HEALTH, V7, P255